Document Detail

Anti-progesterones: background and clinical physiology.
MedLine Citation:
PMID:  3069264     Owner:  NLM     Status:  MEDLINE    
The development of anti-progesterones has provided a probe to examine the role of progesterone both in the normal cycle and in pregnancy. The most widely used of these agents, mifepristone, appears to act both directly at the endometrial progesterone receptor, and centrally by reducing circulating gonadotrophin concentrations. In addition, ovarian steroidogenesis may be modified. The clinical application of these agents for the interruption of pregnancy will be considered in the following chapters.
I T Cameron; D L Healy
Related Documents :
21485724 - Doppler assessment between pathological examination of the placenta and late fetal intr...
23478074 - Expression of corticotrophin-releasing hormone and its receptor in patients with intrah...
3208514 - Why does ru486 fail to prevent implantation despite success in inducing menstruation?
6671464 - Metabolism of 14c-pregnenolone in the placenta throughout pregnancy in organ culture.
3939974 - Is the sex ratio at birth affected by immune selection?
20090114 - Maternal nutrition & low birth weight - what is really important?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Baillière's clinical obstetrics and gynaecology     Volume:  2     ISSN:  0950-3552     ISO Abbreviation:  Baillieres Clin Obstet Gynaecol     Publication Date:  1988 Sep 
Date Detail:
Created Date:  1989-05-10     Completed Date:  1989-05-10     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8710782     Medline TA:  Baillieres Clin Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  597-607     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents / therapeutic use*
Abortifacient Agents, Steroidal / pharmacokinetics,  pharmacology,  therapeutic use*
Estrenes / pharmacokinetics,  pharmacology,  therapeutic use*
Macaca fascicularis
Receptors, Progesterone / biosynthesis,  drug effects*,  genetics
Reg. No./Substance:
0/Abortifacient Agents; 0/Abortifacient Agents, Steroidal; 0/Estrenes; 0/Receptors, Progesterone; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anti-oestrogens in the treatment of breast and gynaecological cancers.
Next Document:  Anti-progesterones for the interruption of pregnancy.